MiMedx Group logo

MiMedx Group (MDXG) Q1 2025 Earnings

MDXG·Reported April 30, 2025·After market close

MiMedx Group reported Q1 2025 revenue of $88.2M (+4.1% YoY), beat analyst consensus of $86.3M by $1.9M. Diluted EPS came in at $0.06 (-14.3% YoY).

Revenue
$88.2Mbeat by $1.9M
Consensus: $86.3M
Diluted EPS
$0.06met estimate
Consensus: $0.06
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2025

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about MiMedx Group's Q1 2025 earnings report.

MiMedx Group (MDXG) reported Q1 2025 earnings on April 30, 2025 after market close.

MiMedx Group reported revenue of $88.2M and diluted EPS of $0.06 for Q1 2025.

Revenue beat the consensus estimate of $86.3M by $1.9M. EPS beat the consensus estimate of $0.06 by $0.00.

Compared to the same quarter a year prior, revenue grew 4.1% from $84.7M a year earlier and diluted EPS declined 14.3% from $0.07.

You can read the 10-Q periodic report (0001376339-25-000045) directly on SEC EDGAR. The filing index links above go to sec.gov.